MMP9 and colorectal carcinoma: Specifically, the dual action of MMP9 in promoting CRC progression through ECM remodeling and influencing neuropathic pain by altering myelin dynamics presents a complex scenario (Chattopadhyay et al., 2007; Kobayashi et al., 2008).